1. Home
  2. PI vs SRRK Comparison

PI vs SRRK Comparison

Compare PI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Impinj Inc.

PI

Impinj Inc.

N/A

Current Price

$143.46

Market Cap

5.8B

Sector

Technology

ML Signal

N/A

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$48.36

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PI
SRRK
Founded
2000
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.2B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
PI
SRRK
Price
$143.46
$48.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
18
Target Price
★ $206.44
$70.06
AVG Volume (30 Days)
297.0K
★ 1.5M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $122,633,000.00
N/A
Revenue This Year
$10.27
N/A
Revenue Next Year
$19.25
$662.10
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$87.96
$38.69
52 Week High
$215.25
$61.76

Technical Indicators

Market Signals
Indicator
PI
SRRK
Relative Strength Index (RSI) 29.87 56.01
Support Level $127.05 $44.88
Resistance Level $151.68 $50.56
Average True Range (ATR) 9.58 2.95
MACD -2.64 0.48
Stochastic Oscillator 3.24 57.77

Price Performance

Historical Comparison
PI
SRRK

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: